Scotts Miracle-Gro climbs as UBS upgrades stock on valuation
Scotts Miracle-Gro SMG rose 7.2% after UBS upgraded it to Buy, citing attractive valuation. UBS lowered its price target to $70, seeing 40% upside. The firm expects earnings growth through productivity and pricing, with organic revenue growth outpacing consensus. Higher-income households now account for 43% of sales, up from 26% in 2019. E-commerce and strong brand positions also support growth.
How this was made
The 30-second read
Why it matters
UBS’s Buy upgrade reframes the stock as undervalued versus its own history and peers, and ties the investment case to productivity, higher-margin mix, and pricing that could lift organic growth and adjusted EPS in fiscal 2027-2028.
Market read
Traders can use the upgrade and the detailed fiscal 2027-2028 growth and margin expectations to gauge whether the market is likely to sustain a valuation-driven re-rating.
What to watch
The article highlights higher-income and e-commerce mix shifts, but does not quantify sustainability of those mix changes or competitive pricing risk in fertilizer and pest control categories.
Background
Scotts Miracle-Gro has faced consumer spending pressure tied to inflation, elevated rates, and a sluggish housing market, leading to underperformance since its August analyst day.
Ticker impact
UBS upgraded Scotts Miracle-Gro to Buy from Neutral and cut its 12-month PT to $70, citing valuation and margin/profitability upside despite consumer pressure.
Likely upward bias as the market digests the Buy call and margin-growth thesis, with some resistance from the lower PT.
The article attributes the same-day rally to UBS’s upgrade and provides specific EPS/revenue growth and margin trajectory assumptions that drive the re-rating case.
Market effects
Supports sentiment for lawn and garden retail names by reinforcing a valuation and margin-recovery framework amid consumer and housing headwinds.
No specific regional spillover beyond US small/mid-cap consumer discretionary sentiment.
Limited, as the catalyst is a single-company analyst action and US consumer-demand framing.
Counterpoint
The thesis still depends on continued margin expansion and pricing power while inflation, rates, and housing remain headwinds, so the upgrade may fade if demand weakens.
Key entities
- companyScotts Miracle-Gro
Lawn and garden products maker whose shares rose after UBS upgraded the stock and outlined margin and earnings growth assumptions.
- analyst_firmUBS
Issued the upgrade to Buy from Neutral and provided the $70 base-case PT with upside/downside scenarios.
- analystPeter Grom
UBS analyst who lowered the 12-month price target and argued valuation has fallen to levels last seen in October 2023.
